Zhimin Zhang

Shiyan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Mechanism of Curcumin in Inhibiting Proliferation of Head and Neck Squamous Cell Carcinoma: A Network Pharmacology and Cellular Experimental Study.

Mechanism of Curcumin in Inhibiting Proliferation of Head and Neck Squamous Cell Carcinoma: A Network Pharmacology and Cellular Experimental Study.

Journal: BioMed research international

Published: April 07, 2025

NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma.

NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: August 11, 2024

The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis.

The efficacy of immune checkpoint inhibitors is limited in elderly NSCLC: a retrospective efficacy study and meta-analysis.

Journal: Aging

Published: July 29, 2023

Complement C1q induces the M2-polarization of tumor-associated macrophages in lung adenocarcinoma.

Complement C1q induces the M2-polarization of tumor-associated macrophages in lung adenocarcinoma.

Journal: Genes & diseases

Published: December 28, 2022

Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors.

Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors.

Journal: Thoracic cancer

Published: June 21, 2022

Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC.

Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC.

Journal: Frontiers in oncology

Published: January 27, 2021

Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.

Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.

Journal: Molecular medicine reports

Published: April 28, 2020

LncRNA LUADT1 sponges miR-195 to prevent cardiac endothelial cell apoptosis in sepsis.

LncRNA LUADT1 sponges miR-195 to prevent cardiac endothelial cell apoptosis in sepsis.

Journal: Molecular medicine (Cambridge, Mass.)

Published: March 17, 2020

Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation.

Dihydroartemisinin sensitizes Lewis lung carcinoma cells to carboplatin therapy via p38 mitogen-activated protein kinase activation.

Journal: Oncology letters

Published: May 15, 2016

High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma.

High expression of c-Met and EGFR is associated with poor survival of patients with glottic laryngeal squamous cell carcinoma.

Journal: Oncology letters

Published: September 28, 2015

Clinical efficacy of percutaneous vertebroplasty combined with intensity-modulated radiotherapy for spinal metastases in patients with NSCLC.

Clinical efficacy of percutaneous vertebroplasty combined with intensity-modulated radiotherapy for spinal metastases in patients with NSCLC.

Journal: OncoTargets and therapy

Published: August 29, 2015

MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.

MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells.

Journal: Molecular medicine reports

Published: September 24, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026